Hey Guys,
Thought I'd start a new thread on stem-cell therapy milestones. For me the regulatory landscape made a significant shift with COVID-19 stem-cell treatments being included in FDA trials (see other threads to gauge how the FDA is engaging properly trialed stem-cell therapies). To me this all changes the wider environment for acceptance of stem-cell treatments including OCC's ATI treatment, the obvious gold-star treatment for degenerative tendons. Presumably many of you will be interested in general stem-cell therapies on a wider front. Another recent milestone:
https://medicalxpress.com/news/2020-05-japan-newborn-liver-stem-cells.html
Stem-cell treatment in a newborn is really breaking conservative boundaries in medicine....
Stem Cell Therapy advancements
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.0¢ | $213.0K | 575.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61683 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 18300 | 1 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
37.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 37.5¢ | 38.0¢ | 36.5¢ | 191270 | ||
| Last updated 15.00pm 22/05/2024 ? | |||||
| OCC (ASX) Chart |